Rana Isguder
Overview
Explore the profile of Rana Isguder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gezgin Yildirim D, Orulluoglu E, Yildiz C, Acari C, Dundar H, Akaci O, et al.
Pediatr Rheumatol Online J
. 2025 Mar;
23(1):24.
PMID: 40069880
Background: Cyclophosphamide (CYC) is an inactive alkylating agent that transforms the alkyl radicals into other molecules and is used in combination with systemic corticosteroids in the treatment of many childhood...
2.
Demirci Yildirim T, Isguder R, Karacura E, Erez Y, Makay B, Onen F, et al.
Arch Rheumatol
. 2025 Mar;
39(4):662-669.
PMID: 40060127
Objectives: This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology. Patients...
3.
Sahin N, Baykal G, Acari C, Avar Aydin P, Baba O, Baglan E, et al.
Pediatr Rheumatol Online J
. 2024 Dec;
22(1):105.
PMID: 39695685
Background: The field of transitional care for chronic conditions in adolescents, notably juvenile idiopathic arthritis (JIA), is rapidly growing. Transitioning these patients to adult healthcare systems presents significant challenges in...
4.
Sonmez H, Batu E, Isguder R, Sahin N, Aliyev E, Aslan E, et al.
Lupus
. 2024 Aug;
33(12):1358-1364.
PMID: 39186467
Objective: Systemic lupus erythematosus (SLE) constitutes an autoimmune disorder with potential involvement of the gastrointestinal system (GIS). Our objective was to assess the gastrointestinal (GI) manifestations in patients diagnosed with...
5.
Sunar Yayla E, Gezgin Yildirim D, Dundar H, Adrovic A, Akboru E, Aktay Ayaz N, et al.
Eur J Pediatr
. 2024 Jun;
183(9):3959-3968.
PMID: 38926187
Conclusions: RTX has become a common treatment option in pediatric rheumatology in recent years. Treatment management may vary between clinician such as vaccination and routine tests. What Is Known: •...
6.
Ulu K, Isguder R, Karadag S, Baglan E, Kavrul Kayaalp G, Yener G, et al.
Turk J Med Sci
. 2024 May;
53(5):1105-1111.
PMID: 38813038
Background/aim: Chronic nonbacterial osteomyelitis (CNO) is a rare disease of unknown etiology and most commonly occurs during childhood or adolescence. The purpose of this study is to collect data on...
7.
Sozeri B, Sahin N, Acari C, Avar Aydin P, Baba O, Baglan E, et al.
Pediatr Rheumatol Online J
. 2024 Jan;
22(1):7.
PMID: 38167070
Background: Juvenile idiopathic arthritis (JIA) is a prevalent childhood chronic arthritis, often persisting into adulthood. Effective transitional care becomes crucial as these patients transition from pediatric to adult healthcare systems....
8.
Isguder R, Kizildag Z, Torun R, Aydin T, Makay B, Unsal E
Arch Rheumatol
. 2023 Dec;
38(4):602-610.
PMID: 38125067
Objectives: The study aimed to determine the factors that increase the risk of disease flare in patients with juvenile idiopathic arthritis who stopped methotrexate (MTX) monotherapy following inactive disease (ID)....
9.
Acari C, Isguder R, Torun R, Makay B, Erbil Unsal S
Arch Rheumatol
. 2023 Sep;
38(2):282-290.
PMID: 37680516
Objectives: The aim of this study was to examine the clinical and phenotypic features of pediatric Behçet's disease (PEDBD) in our clinic and present the rates of fulfilling the diagnostic...
10.
Batu E, Sener S, Arslanoglu Aydin E, Aliyev E, Bagrul I, Turkmen S, et al.
Rheumatology (Oxford)
. 2023 May;
63(3):791-797.
PMID: 37228026
Objectives: Colchicine forms the mainstay of treatment in FMF. Approximately 5-10% of FMF patients are colchicine resistant and require anti-IL-1 drugs. We aimed to compare the characteristics of colchicine-resistant and...